Dear Friends, 

    As the newly elected President of the European Alliance of Associations for Rheumatology (EULAR), I am honoured to address you all and extend my warmest greetings. Since its founding in 1947, EULAR has been a shining example of excellence in the field of Rheumatology. It has achieved a respected and esteemed reputation of significant importance throughout Europe.  

    At the heart of EULAR's remarkable endeavours, the EULAR European Congress of Rheumatology stands as our flagship event, delivering an unparalleled experience year after year. Our Congress brings together a vast network of patients, health professionals, rheumatologists and industry partners dedicated to highlighting the latest scientific breakthroughs in clinical, translational, and basic research. It serves as a platform for discussing new developments and management of rheumatic and musculoskeletal diseases (RMDs). Furthermore, the Congress focuses on bridging the gap between diagnosis and patient care and explores practical aspects of the rheumatology field through specialised workshops, presentations, and discussions. EULAR 2024

  • Great News


    Clarivate today has just published the new edition of the Journal Citation ReportReumatismo achieved an initial impact factor of 1.4! In the Clarivate’s “RHEUMATOLOGY" category, Reumatismo ranks 45/54, Q4.  

    We would like to express our gratitude to everyone who contributed to the journal. Their continued trust and engagement have motivated us to strive for excellence and continue pushing the boundaries of research.

    As we celebrate this remarkable accomplishment, we remain committed to upholding the highest standards of academic publishing. We will continue to provide a platform for groundbreaking research and foster an environment that promotes collaboration and innovation. Together, we will continue to make significant contributions to the advancement of knowledge and the progress of our fields.

    We look forward to sharing more exciting developments and groundbreaking research with our audience in the future.

  • COVID-19


    Dear Authors,
    a large number of reviewers in Europe and particularly in Italy, are clinicians: their commitment in the current public health emergency is aimed at helping and treating people. Our greatest thanks go to them.

    We renew our commitment to guarantee you the peer-review process of your papers submitted to the Journal as soon as possible and we are confident we have your understanding for possible small delays.

    The Editorial Board
    The Publisher